An $18 billion settlement offer from three major drug wholesalers aimed at resolving litigation over their alleged role in the opioid crisis has fallen apart, after more than 20 state attorneys general rejected it in a letter sent to the companies’ law firms earlier this week.
The letter, reviewed by The Wall Street Journal, shows that the…
